Clinical and preclinical studies have found that impaired insulin signaling induces tau hyperphosphorylation and that insulin-sensitizing strategies improve cerebrospinal fluid biomarkers of tauopathy in patients with MCI/AD (Hölscher, 2014; Yarchoan et al., 2014; Kim et al., 2015). Here, INS is linked to Alzheimer disease.